# Hertzel C. Gerstein

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/hertzel-c-gerstein/

## Facts

| Field | Value |
| --- | --- |
| Citations | 75,575 |
| Field | Diabetes Treatment and Management |
| h-index | 120 |
| i10-index | 411 |
| Last Known Institution | McMaster University Medical Centre |
| OpenAlex ID | https://openalex.org/A5024577116 |
| ORCID iD | https://orcid.org/0000-0001-8072-2836 |
| Works | 754 |

## Researcher papers

Showing 12 of 18.

- [Effects of Intensive Glucose Lowering in Type 2 Diabetes](https://scholariq.org/papers/effects-of-intensive-glucose-lowering-in-type-2-diabetes/)
- [Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial](https://scholariq.org/papers/dulaglutide-and-cardiovascular-outcomes-in-type-2-diabetes-rewind-a-double-blind/)
- [Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome](https://scholariq.org/papers/lixisenatide-in-patients-with-type-2-diabetes-and-acute-coronary-syndrome/)
- [Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials](https://scholariq.org/papers/cardiovascular-mortality-and-kidney-outcomes-with-glp-1-receptor-agonists-in-2/)
- [Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized Trial](https://scholariq.org/papers/renal-insufficiency-as-a-predictor-of-cardiovascular-outcomes-and-the-impact-of/)
- [Intensive glucose control and macrovascular outcomes in type 2 diabetes](https://scholariq.org/papers/intensive-glucose-control-and-macrovascular-outcomes-in-type-2-diabetes/)
- [Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus](https://scholariq.org/papers/primary-prevention-of-cardiovascular-diseases-in-people-with-diabetes-mellitus-2/)
- [Myocardial Injury after Noncardiac Surgery](https://scholariq.org/papers/myocardial-injury-after-noncardiac-surgery/)
- [Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus](https://scholariq.org/papers/primary-prevention-of-cardiovascular-diseases-in-people-with-diabetes-mellitus/)
- [Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial](https://scholariq.org/papers/dulaglutide-and-renal-outcomes-in-type-2-diabetes-an-exploratory-analysis-of-the/)
- [Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: A systematic overview and meta-analysis of prospective studies](https://scholariq.org/papers/annual-incidence-and-relative-risk-of-diabetes-in-people-with-various-categories/)
- [Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials](https://scholariq.org/papers/effects-of-intensive-glucose-control-on-microvascular-outcomes-in-patients-with/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Hyperglycemia and glycemic control in critically ill and hospitalized patients](https://scholariq.org/topics/hyperglycemia-and-glycemic-control-in-critically-ill-and-hospitalized-patients/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)

## Researcher university

- [McMaster University Medical Centre](https://scholariq.org/institutions/mcmaster-university-medical-centre/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.